• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, May 18, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Major discovery provides new hope for blood cancer patients

Bioengineer by Bioengineer
May 9, 2022
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

South Australian scientists have made a significant breakthrough in overcoming drug resistance in acute myeloid leukaemia (AML), a rare and devastating blood cancer that kills most patients within a few years.

Scientists identify protein promoting AML drug resistance

Credit: University of South Australia

South Australian scientists have made a significant breakthrough in overcoming drug resistance in acute myeloid leukaemia (AML), a rare and devastating blood cancer that kills most patients within a few years.

In a new study published in the world-leading hematology journal Blood, researchers from the University of South Australia and SA Pathology’s Centre for Cancer Biology describe how they have discovered a way to suppress a specific protein that promotes resistance to drugs commonly used to treat AML patients.

Professor Stuart Pitson, one of the lead authors of the study, says the finding could revolutionise the treatment of AML, a disease that has claimed the lives of Australian football great Russell Ebert, professional golfer Jarrod Lyle, high-profile American journalist Nora Ephron and filmmaker Lynn Shelton.

This year, it is estimated that 20,000 people in the United States and 900 people in Australia will be diagnosed with acute myeloid leukaemia, a cancer of the blood and bone marrow characterised by an overproduction of cancerous white blood cells called leukaemic blasts.

Prof Pitson says these cells crowd out normal white blood cells, which then can’t do their usual infection-fighting work, thereby increasing the risk of infections, low oxygen levels and bleeding.

SA Pathology haematologist Associate Professor David Ross says many AML patients initially respond to Venetoclax, a new therapy for AML recently listed on the PBS, but over time AML cells become resistant to it.

Using a large biobank of patient-donated AML biopsies and world-leading advanced pre-clinical models, the CCB researchers demonstrated that by modulating lipid metabolism in the body, a protein called Mcl-1 is inhibited in AML cells – the protein that facilitates drug resistance.

 “This process makes AML cells exquisitely sensitive to Venetoclax, while leaving the normal white blood cells unaffected,” SA Pathology researcher and co-lead author, Associate Professor Jason Powell says.

The CCB team is now working hard to optimise drugs targeting this pathway to take into clinical trials for AML patients.

“For most people with AML, the chances of long-term survival are no better now than they were last century,” Assoc Prof Ross says.

“Now, we have a chance to remedy that. New treatments that prevent Venetoclax resistance have the potential to prolong survival, or even increase the chances of a cure in a disease for which improved outcomes are desperately needed.”

For a full copy of the paper, please email [email protected]

Notes for editors

Acute myeloid leukaemia (AML) accounts for approximately 0.8 per cent of all cancers diagnosed, at a rate of 3.7 per 100,000 people. It can occur at any age but is more common in adults (and men) over the age of 60.

In most cases the causes remain unknown, but it is thought to result from damage to one of more genes that normally control blood cell development.

Current therapies are effective at putting patients into remission, but relapse is common, with fewer than 30 per cent of AML patients surviving five years post diagnosis.

In 1990, acute myeloid leukemia (AML) accounted for 18.0% of the total leukemia cases worldwide. This proportion increased to 23.1% in 2017. 

 



Journal

Blood

DOI

10.1182/blood.2021013277

Method of Research

Experimental study

Subject of Research

Cells

Article Title

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia

Article Publication Date

20-Apr-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Gwangju Institute of Science and Technology Researchers Develop a Tool for Studying Inflammatory Diseases Related to COVID-19

Gwangju Institute of Science and Technology researchers develop a tool for studying inflammatory diseases related to COVID-19

May 16, 2022
Figure 1

How fat could help in tailoring cancer treatment plans

May 16, 2022

New project coordinated by the BSC aims to revolutionize the detection of breast cancer using ultrasound imaging

May 16, 2022

Once upon a barbeque-time…Think twice before you start

May 13, 2022

POPULAR NEWS

  • Weybourne Atmospheric Observatory

    Breakthrough in estimating fossil fuel CO2 emissions

    46 shares
    Share 18 Tweet 12
  • Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find

    44 shares
    Share 18 Tweet 11
  • Discovery of the one-way superconductor, thought to be impossible

    43 shares
    Share 17 Tweet 11
  • Sweet discovery could drive down inflammation, cancers and viruses

    42 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Weather/StormsUrbanizationVaccinesVirusWeaponryUrogenital SystemVaccineZoology/Veterinary ScienceViolence/CriminalsVirologyUniversity of WashingtonVehicles

Recent Posts

  • Pancharatnam–Berry phase reversal via opposite-chirality-coexisted superstructures
  • Reliable diagnostics at the tip of your finger
  • Seafloor animal cued to settle, transformed by a bacterial compound
  • Tooth unlocks mystery of Denisovans in Asia
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....